ResearcherInstitut de Cancérologie de Montpellier (ICM)No recent work listed
Fabienne Portalès
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 0
- Pancreatic cancer trials
- 2
- Pancreatic cancer grants
- 0
- Collaborators
- 0
2021: 1 trial · 2022: 1 trial
Trials 2
- Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients Study chair NCT05065801↗
- Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer Study chair NCT04570943↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.